Amanote Research
Register
Sign In
Impact of Implementing International Reference Pricing on Pharmaceutical Prices for United States Medicare
Value in Health
- United Kingdom
doi 10.1016/j.jval.2016.03.1813
Full Text
Open PDF
Abstract
Available in
full text
Categories
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Date
May 1, 2016
Authors
J. Weiss
P. Hakim
R. Degun
Publisher
Elsevier BV
Related search
Intellectual Property and Pharmaceutical Prices in the United States
The Southwest Respiratory and Critical Care Chronicles
Pmu32 - Orphan Drug Prices in Europe: Impact of External Reference Pricing
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Coordinating on Lower Prices: Pharmaceutical Pricing Under Political Pressure
RAND Journal of Economics
Economics
Econometrics
The Effect of Medicare Part D on Pharmaceutical Prices and Utilization
American Economic Review
Economics
Econometrics
Prs69 - Impact of the International Reference Pricing on Access to Standard Therapy Drugs for Copd
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Prm7 Drug Development and Pharmaceutical Pricing in the United States: The Influence of Drug Intended Outcomes of Drug Pricing
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Differential Pharmaceutical Pricing: Are Prices Co-Related With GDP?
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Conceputalizing a Model to Assess the Impact of International Reference Pricing Reforms
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Reference Pricing on Biotherapeutic Drugs: Monitoring of the Insulin Wholesale Prices in Ukraine
Upravlìnnâ, ekonomìka ta zabezpečennâ âkostì v farmacìï
